Rezolute, Inc. — Director's Dealing 2013

Feb 9, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2013-01-31

Reporting Person: Howe Steve (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to purchase Common Stock	$0.75	2018-01-30	Common Stock (2000000)		Direct

Footnotes

F1: (1) Pursuant to the terms of the Reporting Person's option to purchase common stock ("Common Stock Option"), 50% of the Common Stock Option vested on January 30, 2013 with the remaining 50% of the Common Stock Option to vest monthly over the thirty-six months following January 30, 2013. Pursuant to a domestic relations order, Mrs. Howe is entitled to 50% of the 2,000,000 shares of common stock issuable upon the exercise of Mr. Howe's Common Stock Option. In accordance with the domestic relations order, Mr. Howe will transfer the vested portion of the Common Stock Option as of January 30, 2013 (the option to purchase 1,000,000 common shares of common stock of the Issuer) over which he disclaims beneficial ownership or pecuniary interest